Imperial College London Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"human"×
10 miles

Pharmaceutical / Medicinal Chemistry (human) PhD Projects, Programs & Scholarships

We have 22 Pharmaceutical / Medicinal Chemistry (human) PhD Projects, Programs & Scholarships

  • "human" ×
  • Pharmaceutical / Medicinal Chemistry×
  • clear all
Order by 
Showing 1 to 10 of 22
  Impact of normal and premature ageing on human macro- and microvasculature
  Research Group: Centre for Skin Sciences
  Dr K Riches-Suman, Dr M J Thornton
Applications accepted all year round

Funding Type

PhD Type

The global population is growing, with the number of births consistently higher than the number of deaths. This is because people are living for longer, due at least in part to improved lifestyle and healthcare provision.
  Molecular mechanisms of herpesviral infection
  Dr A Golovanov
Applications accepted all year round

Funding Type

PhD Type

Herpes viruses are known to cause a wide range of human diseases, ranging from simple cold sores to cancer, Kaposi Sarcoma. Kaposi Sarcoma, for example, is a type of cancer which affects immunocompromised patients and is endemic in Africa, where it is linked with the spread of HIV infection and AIDS.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round

Funding Type

PhD Type

Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
  Inhibiting cell metabolism to enhance tumour cell death
  Dr C Bubici, Dr S Papa
Application Deadline: 31 January 2020

Funding Type

PhD Type

As you read this, millions of your cells from your body are dying. Do not panic – this is not bad news. Most of them are either superfluous or potentially harmful, so you are better off without them.
  GW4 BioMed MRC DTP PhD studentship: Making Broken Bones Antimicrobial - Preventing Osteomyelitis Using a Targeted and Mineralising Liposomal Delivery System
  Dr WN Nishio Ayre, Prof J Birchall
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September/October 2019.
  Investigating the druggability of the motif-mediated interactome with peptide PROTACs
  Dr N Davey, Dr S Guettler, Prof J Pines
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Comparative genomic analysis of variant features within the Neisseria spp.
  Dr L Snyder
Applications accepted all year round

Funding Type

PhD Type

The availability of rapid genome sequencing had generated an explosion of bacterial genome sequence data, much of which has not been fully explored and investigated.
  Developing effective measurement techniques for the assessment of Furan Fatty Acids levels
  Dr M Kimber
Application Deadline: 31 July 2020

Funding Type

PhD Type

The Furan Fatty Acids (FFAs) are an important class of natural products due to their nutritional health benefits and impact on inflammatory & cardiovascular…
  Synthetic and Mechanistic Studies into Enzymatic Degradation of Waste Plastics
  Dr L Wong, Dr C F Blanford
Applications accepted all year round

Funding Type

PhD Type

Plastics are a broad range of solid polymeric materials that have found widespread application as industrial components and consumer goods.
  Tyrosine kinase inhibitors conjugated tumour targeting dyes for the treatment of glioblastoma.
  Dr J Jose, Dr P Choi
Applications accepted all year round

Funding Type

PhD Type

Glioblastoma (GBM) remains a lethal and difficult to treat cancer with a dismal outcome. Although we have a better understanding of the disease progression, a concurrent increase in therapeutic intervention is lagging.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.